Brief: Panbela Announces Sponsored Research Agreement
13/06/2023 14:34
June 13 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA ANNOUNCES SPONSORED RESEARCH AGREEMENT TO EVALUATE
POLYAMINE METABOLIC INHIBITOR THERAPY IN COMBINATION WITH CAR-T
CELL THERAPY
Source text for Eikon: ID:nGNX3tXPl2
Further company coverage: PBLA.O
(reuters.briefs@thomsonreuters.com)
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants